These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37458333)
1. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy. Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333 [TBL] [Abstract][Full Text] [Related]
2. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib. Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851 [TBL] [Abstract][Full Text] [Related]
3. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060 [TBL] [Abstract][Full Text] [Related]
4. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism. Li D; Zhang M; Chao H Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856 [TBL] [Abstract][Full Text] [Related]
5. Activatable unsaturated liposomes increase lipid peroxide of cell membrane and inhibit tumor growth. Fu JJ; Liu CC; Feng GN; Li SP; Yu YY; Du LR; Zhang JY; Zhang Y; Lei XP; Dai X; Yu XY Biomater Adv; 2023 Apr; 147():213323. PubMed ID: 36764198 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546 [No Abstract] [Full Text] [Related]
7. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells. Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484 [TBL] [Abstract][Full Text] [Related]
8. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032 [TBL] [Abstract][Full Text] [Related]
9. Amphiphilic Dendrimer Doping Enhanced pH-Sensitivity of Liposomal Vesicle for Effective Co-delivery toward Synergistic Ferroptosis-Apoptosis Therapy of Hepatocellular Carcinoma. Su Y; Zhang Z; Lee LTO; Peng L; Lu L; He X; Zhang X Adv Healthc Mater; 2023 Jan; 12(6):e2202663. PubMed ID: 36653312 [TBL] [Abstract][Full Text] [Related]
10. Ferrocene-liposome-PEG: a robust ˙OH/lipid peroxide nano-converter for inducing tumor ferroptosis. Liu Y; Chen J; He Z; Luo H; Liu X; Sun Y; Ge D; Liu X; Shi W Biomater Sci; 2023 Jan; 11(2):542-553. PubMed ID: 36472166 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy. Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374 [TBL] [Abstract][Full Text] [Related]
12. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification. Feng W; Shi W; Wang Z; Cui Y; Shao X; Liu S; Rong L; Liu Y; Zhang H ACS Appl Mater Interfaces; 2022 Aug; 14(33):37540-37552. PubMed ID: 35944147 [TBL] [Abstract][Full Text] [Related]
13. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer. Zhu G; Chi H; Liu M; Yin Y; Diao H; Liu Z; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K J Colloid Interface Sci; 2022 Sep; 621():12-23. PubMed ID: 35447518 [TBL] [Abstract][Full Text] [Related]
14. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy. Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750 [TBL] [Abstract][Full Text] [Related]
15. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis. Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124 [TBL] [Abstract][Full Text] [Related]
16. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy. Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297 [TBL] [Abstract][Full Text] [Related]
18. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy. Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077 [TBL] [Abstract][Full Text] [Related]
19. Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells. Chen C; Tan Y; Xu T; Sun Y; Zhao S; Ouyang Y; Chen Y; He L; Liu X; Liu H Langmuir; 2022 Oct; 38(40):12307-12315. PubMed ID: 36154182 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy. Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]